Sexuality in the climacteric years

Maturitas

Volumn 43, Issue , 2002, Pages 69-77

  Palacios, S ^a   Tobar, A C ^a   Menendez, C ^a  

^a Palacio Inst of Research In Gynaecology and Metabolism   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; GESTAGEN; SEX HORMONE; STEROID RECEPTOR; TESTOSTERONE;

AGING; ANAMNESIS; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; CLIMACTERIUM; DIAGNOSTIC PROCEDURE; DRUG USE; HORMONE DETERMINATION; HUMAN; LIBIDO; MEDICAL EDUCATION; MENOPAUSE; OVARY; PALLIATIVE THERAPY; PATIENT CARE; PHYSIOLOGY; PREVALENCE; PSYCHOLOGY; REVIEW; SEX THERAPY; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUALITY; WELLBEING;

AGING; ANDROGEN ANTAGONISTS; ANDROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; NORPREGNENES; SEXUALITY;

EID: 0037200683     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(02)00150-0     Document Type: Article

References (43)

1. Gruis M.L., Wagner N.N. Sexuality during the climacteric. Postgrad. Med. 65:(5):1979;197-207.
2. Lobo R.A. Androgens in postmenopausal women: production, possible role, and replacement options. Obstet. Gynecol. Surv. 56:(6):2001;361-376.
3. Simpson E. Why do the clinical sequelae of estrogen deficiency affect women more than men? J. Clin. Endocrinol. Metab. 83:(6):1998;2214-2215.
4. Shifren J., Schiff I. The aging ovary. J. Womens Health Gend. Based Med. 9:(Suppl. 1):2000;S3-S7.
5. Longcope C. Endocrine function of the postmenopausal ovary. J. Soc. Gynecol. Investig. 8:(Suppl. 1 Proceedings):2001;S67-S68.
6. Labrie F., Luu-The V., Labrie C., Simard J. DEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front. Neuroendocrinol. 22:(3):2001;185-212.
7. Rako S. Testosterone supplemental therapy after hysterectomy with or without concomitant oophorectomy: estrogen alone is not enough. J. Womens Health Gend. Based Med. 9:(8):2000;917-922.
8. Morley J.E. Androgens and aging. Maturitas. 38:2001;61-71.
9. Davis S. Testosterone deficiency in women. J. Reprod. Med. 46:(Suppl. 3):2001;291-296.
10. DeCherney A. Hormone receptors and sexuality in the human female. J. Womens Health Gend. Based Med. 9:(Suppl. 1):2000;S9-S13.
11. Stormati M., Hartmann B., Spinetti A., Mailand D., Rubiano S., Albrecht A., et al. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women. J. Endocrinol. Invest. 19:(8):1996;535-541.
12. Genazzani A.R., Spinetti A., Gallo R., Bernardi F. Menopause and the central nervous system: intervention options. Maturitas. 31:(2):1999;103-110.
13. Genazzani A.R., Stomati M., Morittu A., Bernardi F., Casarosa M.P., et al. Progesterone, progestagens and the central nervous system. Hum. Reprod. 15:(Suppl. 1):2000;14-27.
14. Genazzani A.R., Bernardi F., Stomati M., Luisi M., Luisi M. Hormone replacement therapy: effects on neurotransmitters, neuropeptides, neurosteroids and the quality of life. Menopause Rev. VI:(2):1999;10-21.
15. Shughrue P.J., Scrimo P.J., Merchenthaler I. Estrogen binding and estrogen receptor characterization (ER alpha and ER beta) in the cholinergic neurons of the rat basal forebrain. Neuroscience. 96:(1):2000;41-49.
16. Rissman E.F., Early A.H., Taylor J.A., Korach K.S., Lubahn D.B. Estrogen receptors are essential for female sexual receptivity. Endocrinology. 138:(1):1997;507-510.
17. Herbison A.E., Pape J.R. New evidence for estrogen receptors in gonadotropin-releasing hormone neurons. Front. Neuroendocrinol. 22:(4):2001;292-308.
18. Becu-Villalobos D., Gonzalez Iglesias A., Diaz-Torga G., Hockl P., Libertun C. Brain sexual differentiation and gonadotropins secretion in the rat. Cell. Mol. Neurobiol. 17:(6):1997;699-715.
19. Young L.J., Wang Z., Donaldson R., Rissman E.F. Estrogen receptor alpha is essential for induction of oxytocin receptor by estrogen. Neuroreport. 9:(5):1998;933-936.
20. Hull E.M., Lorrain D.S., Du J., Matuszewich L., Lumley L.A., Putnam S.K., et al. Hormone-neurotransmitter interactions in the control of sexual behavior. Behav. Brain Res. 105:(1):1999;105-116.
21. Sarrel P.M. Psychosexual effects of menopause: role of androgens. Am. J. Obstet. Gynecol., Part 2. 180:(3):1999;S319-S324.
22. Heiman J.R. Female sexual dysfunction (FSD) in menopausal women: definitions and epidemiology. Menopause Rev. VI:(4):1999;11-15.
23. Gelfand M.M. Sexuality among older women. J. Womens Health Gend. Based Med. 9:(Suppl. 1):2000;15-20.
24. Kingsberg S. The psychological impact of aging on sexuality and relationships. J. Womens Health Gend. Based Med. 9:(Suppl. 1):2000;S33-S38.
25. Dennerstein L., Dudley E., Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil. Steril. 76:(3):2001;456-460.
26. Sarrel P.M. Sexuality and menopause. Obstet. Gynecol. 75:(Suppl. 4):1990;26S-30S.
27. Andrews W. Approaches to taking a sexual history. J. Womens Health Gend. Based Med. 9:(Suppl. 1):2000;S21-S24.
28. Murray W. Decreased libido in postmenopausal women. Nurse Pract. Forum. 11:(4):2000;219-224.
29. Gelfand M.M. Sexuality among older women. J. Womens Health Gend. Based Med. 9:(Suppl. 1):2000;S15-S20.
30. Davis S.R. The role of androgens and the menopause in the female sexual response. Int. J. Impot. Res. 10:(Suppl. 2):1998;S82-S83.
31. Davis S.R. The therapeutic use of androgens in women. J. Steroid. Biochem. Mol. Biol. 69:(1-6):1999;177-184.
32. Davis S. Androgen replacement in women: a commentary. J. Clin. Endocrinol. Metab. 84:(6):1999;1886-1891.
33. Davis S.R. Androgens and female sexuality. J. Gend. Spec. Med. 3:(1):2000;36-40.
34. Casson P.R., Carson S.A., Buster J.E. Testosterone delivery systems for women: present status and future promise. Semin. Reprod. Endocrinol. 16:(2):1998;153-159.
35. Basson R. Androgen replacement for women. Can. Fam. Physician. 45:1999;2100-2107.
36. Rigano A., Rigano M., Cancellieri F., Pulle C. Sexually and well being in early menopause. effect of transdermal estradiol therapy. Panminerva Med. 43:(2):2001;115-118.
37. Sarrel P.M. Effects of hormone replacement therapy on sexual psychology and behavior in postmenopause. J. Womens Health Gend. Based Med. 9:(Suppl. 1):2000;S25-S32.
38. Munarriz R., Talakoub L., Flaherty E., Gioia M., Hoag L., Kim N.N., et al. Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire results. J. Sex Marital Ther. 28:(Suppl. 1):2002;165-173.
39. Miller K.K. Androgen deficiency in women. J. Clin. Endocrinol. Metab. 86:(6):2001;2395-2401.
40. Doren M., Rubig A., Coelingh Bennink H.J., Holzzgreve W. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertil. Steril. 75:(3):2001;554-559.
41. Kokcu A., Ceetinkaya M.B., Yanik F., Alper T., Malatyalioglu E. The comparison of tibolone and conjugated estrogen-medroxiprogesterone acetate therapy on sexual performance in postmenopausal women. Maturitas. 36:2000;75-80.
42. Palacios S., Menendez C., Jurado A.R., Castaño R., Vargas J.C. Changes in sex after menopause: effects of tibolone. Maturitas. 22:1995;155-161.
43. Levin R.J. The impact of the menopause on the physiology of genital function. Menopause. Rev. VI:(4):1999;23-31.